TMFEBCapital

Todd Campbell

TMFEBCapital’s Activity

Today

NL

Article

EBCapitalMarkets published an article 12:53 PM

Why Shares in Health Net, Inc. Soared 10% Today

Centene Corp is acquiring Health Net, Inc. for $6.8 billion.

NL

Article

EBCapitalMarkets published an article 10:11 AM

Why Shares in Receptos Soared 15% in June

Receptos shares took off last month following rumors of a potential acquisition.

Yesterday

NL

Article

EBCapitalMarkets published an article 5:06 PM

Why Humana's Shares Tumbled 10% in June

After acquisition rumors led to a big move up in May, Humana Inc.'s shares gave back some of their gains last month.

NL

Article

EBCapitalMarkets published an article 2:49 PM

Why Exelixis, Inc. Shares Slumped Today

Exelixis Inc.'s FDA review for approval of cobimetinib has been delayed until November.

Fri Jun 26

NL

Article

EBCapitalMarkets published an article 1:31 PM

Why Zoetis Inc. Shares Are Tumbling

Rumors are causing shares in Zoetis Inc. to swing wildly over the past two days.

Thu Jun 25

NL

Article

EBCapitalMarkets published an article 1:48 PM

3 Hospital Stocks Are Jumping -- Is 1 A Buy?

The Supreme Court's decision to leave subsidies intact is a boon to hospitals.

NL

Article

EBCapitalMarkets published an article 11:52 AM

Why Tenet Healthcare Corporation Shares Are Soaring

Tenet Healthcare Corporation's shares are soaring following a Supreme Court decision reaffirming Obamacare subsidies.

NL

Article

EBCapitalMarkets published an article 11:13 AM

Why This Small Cap Biotech Stock Is Becoming One of My Favorites

Potential growth for the newly acquired Nucynta makes Depomed Inc. increasingly interesting to investors.

NL

Article

EBCapitalMarkets published an article 10:31 AM

Wow! The Supreme Court Upheld Subsidies in King v. Burwell

The Supreme Court has sided with the government in the King v. Burwell case.

NL

Article

EBCapitalMarkets published an article 12:00 AM

The Biotech Drug Lord: How One Man Is Conquering The Biotech Space

Phillip Frost's Opko Health shares are soaring, but The Fool's Michael Douglass and Todd Campbell worry that valuation has become a bit stretched. Here's why.

Wed Jun 24

NL

Article

EBCapitalMarkets published an article 1:46 PM

Capping Coinsurance on Pricey Meds -- Is This the Future of Health Insurance in America?

California's Covered California marketplace will limit coinsurance on expensive medicine beginning in 2016.

NL

Article

EBCapitalMarkets published an article 12:47 PM

Will Your State Be Hit Hardest If Obamacare Subsidies Are Cut?

A Supreme Court decision is looming that could eliminate health insurance subsidies for millions of Americans.

Tue Jun 23

NL

Article

EBCapitalMarkets published an article 4:32 PM

Using a DCF Model to Value Biotech Stocks

Biotech stocks are incredibly difficult to value, but this approach could help make it a bit simpler.

NL

Article

EBCapitalMarkets published an article 12:45 PM

Why Second Sight Medical Products, Inc. Shares Are Soaring

Investors are applauding study results for Second Sight Medical Products' Argus II prosthesis.

NL

Article

EBCapitalMarkets published an article 11:20 AM

How the 3 Richest Men in the World Became the Wealthiest of the Wealthy

Bill Gates, Carlos Slim, and Warren Buffett are the richest men in the world for a reason.

Mon Jun 22

NL

Article

EBCapitalMarkets published an article 1:13 PM

Why Epizyme Inc. Shares Are Soaring

Epizyme Inc. has reported intriguing early stage trial results in non-Hodgkin lymphoma.

Sat Jun 20

NL

Article

EBCapitalMarkets published an article 10:13 AM

Are Health Insurers Coming Down With a Bad Case of Merger-Mania?

Rumors that major health insurers are courting one another could shake up the health insurance industry.

Fri Jun 19

NL

Article

EBCapitalMarkets published an article 1:35 PM

Did China Just Crush Gilead Sciences' Dreams?

China has rejected Gilead Sciences' Sovaldi patent application.

NL

Article

EBCapitalMarkets published an article 11:35 AM

Why Healthways, Inc. Shares Burst Today

Healthways, Inc. shares tumbled after it cut its full year sales outlook.

NL

Article

EBCapitalMarkets published an article 9:56 AM

Is Teva Pharmaceutical's Day of Reckoning Upon It?

A court decision invalidating a key patent clears the way for Novartis and Momenta to launch their Copaxone biosimilar.

Show More Activity ...

CAPS Stats & Trivia

CAPS Player Rating 65.95
Player Rank 25616 out of 75215
Score 164.11
Score Change Today -2.45
Accuracy 55.88%
Active Picks 34
Total Picks 34
Best Pick MNST (+86.93)
Worst Pick SFM (-53.37)
Average Score per Pick 4.83
Charms Earned 6
Highest Rated Favorite No Favorites Selected
Go to TMFEBCapital’s CAPS page

Boards Stats & Trivia

Board Posts 0
Recs Received 0
People who have rec'd these posts 0
Recs to Posts Ratio (last 30 days) N/A
Threads Started 0
Threads Started Percentage 0.00 %
Most Frequent Board N/A
Very First Post N/A
Percentage of Posts Rec'd 100.00 %
Show TMFEBCapital’s 10 Latest Posts